 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 查看: 2287 | 回復(fù): 11 | |||||
[交流]
GSK被調(diào)查，會(huì)對(duì)醫(yī)藥行業(yè)各個(gè)產(chǎn)業(yè)鏈產(chǎn)生什么影響 已有11人參與
|
|||||
| 大家都來(lái)深入淺出的分析一下 |
回復(fù)此樓» 收錄本帖的淘帖專輯推薦
 新藥研發(fā)必備資料 | 行業(yè)動(dòng)態(tài) |
» 猜你喜歡
人工智能賦能聚合物及復(fù)合材料模型應(yīng)用與實(shí)踐
已經(jīng)有0人回復(fù)
-
各國(guó)和國(guó)際組織現(xiàn)行藥典注射用水質(zhì)量標(biāo)準(zhǔn)
已經(jīng)有0人回復(fù)
-
藥理學(xué)論文潤(rùn)色/翻譯怎么收費(fèi)?
已經(jīng)有73人回復(fù)
-
求助用微譜數(shù)據(jù)庫(kù)查詢
已經(jīng)有0人回復(fù)
-
計(jì)算化學(xué)與人工智能驅(qū)動(dòng)的MOFs性能預(yù)測(cè)與篩選技術(shù)
已經(jīng)有0人回復(fù)
-
研三實(shí)驗(yàn)求指導(dǎo)
已經(jīng)有0人回復(fù)
-
金屬材料多尺度計(jì)算模擬技術(shù)與應(yīng)用：微觀機(jī)理到宏觀性能的集成工作
已經(jīng)有0人回復(fù)
-
288分求調(diào)劑
已經(jīng)有0人回復(fù)
-
江西科技師范大學(xué)微生物天然藥物老師介紹
已經(jīng)有23人回復(fù)
-
一志愿蘇州大學(xué) 生物技術(shù)與工程（086001） 初試323分，求調(diào)劑
已經(jīng)有0人回復(fù)
-
三年實(shí)驗(yàn)室工作經(jīng)歷，一志愿華中農(nóng)業(yè)大學(xué)微生物，總分288求調(diào)劑
已經(jīng)有0人回復(fù)
» 本主題相關(guān)商家推薦: (我也要在這里推廣)
buffalo2012
銀蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1957.5
- 帖子: 61
- 在線: 73.8小時(shí)
- 蟲號(hào): 1636297
- 注冊(cè): 2012-02-23
- 專業(yè): 細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)
★
小木蟲: 金幣+0.5, 給個(gè)紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個(gè)紅包，謝謝回帖
|
柳葉刀文章，轉(zhuǎn)自丁香園，分析GSK事件，說(shuō)中國(guó)醫(yī)患問(wèn)題可能與醫(yī)生和某些藥企的不健康關(guān)系有關(guān)，請(qǐng)看下文： Doctors and pharma in China The Lancet Doctor—patient relationships in China are in crisis. Doctors have been injured or even killed by patients at work. One of the major drivers might be the unhealthy and unethical relations between many doctors and some drug companies. On July 8, GlaxoSmithKline (GSK) said that they were investigating allegations that its staff had improperly used cash and other incentives to encourage the prescription of onabotulinumtoxin A (Botox) in China. The company added that “inquiries to date have found no evidence of bribery or corruption in relation to our sales and marketing of therapeutic Botox in China.” The Lancet has no evidence to suggest that the allegations against GSK in China are true. However, some observers claim that bribing doctors to boost drug prescriptions by some drug companies is an open secret, and that this alleged practice has compromised the public's trust in doctors. The varieties of unethical relationships that exist between some doctors and some of the drug companies in China are said to range from cash kickbacks, lavish gifts or entertainment, ghost writing services, sponsored supplements in journals, and all-expenses-paid trips. There is real concern that doctors' prescriptions are therefore not based solely on patient need and clinical evidence, but may be biased by commercial interests. The perceived unethical association between physicians and industry in China is worrying, because it inevitably harms patients as well as doctors. It damages the doctor—patient relationship and, ultimately, China's whole health system. The GSK China allegations, although unproven, have clearly rung an alarm bell for China's regulatory authorities to ensure the drug industry promotes products in a responsible, ethical, and professional way. Chinese doctors should rely on evidence-based clinical guidelines to inform their practice, and are in urgent need of guidance on their collaborations with the drug industry in various areas such as patient care, professional education, and research. Furthermore, training for doctors in China on managing their relationships ethically with the drug industry and other organisations should start at medical school and be part of continuing professional education. |
3樓2013-07-17 14:31:18
cydwood
金蟲 (小有名氣)
- 應(yīng)助: 3 (幼兒園)
- 金幣: 1146
- 帖子: 164
- 在線: 100.3小時(shí)
- 蟲號(hào): 536376
- 注冊(cè): 2008-03-30
- 性別: GG
- 專業(yè): 有機(jī)合成
2樓2013-07-17 13:17:45
先是網(wǎng)上報(bào)紙上罵聲一片，然后磚家出來(lái)澄清，然后。。。。。就沒(méi)有然后了。 4樓2013-07-17 14:33:25
醉臥西風(fēng)
銀蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1484.3
- 紅花: 2
- 帖子: 794
- 在線: 125.5小時(shí)
- 蟲號(hào): 777276
- 注冊(cè): 2009-05-22
- 專業(yè): 有機(jī)合成
5樓2013-07-17 19:26:08
baijiazi
至尊木蟲 (著名寫手)
- 應(yīng)助: 6 (幼兒園)
- 金幣: 13598.4
- 紅花: 3
- 帖子: 2257
- 在線: 1388.6小時(shí)
- 蟲號(hào): 1067163
- 注冊(cè): 2010-07-31
- 性別: GG
- 專業(yè): 無(wú)機(jī)材料化學(xué)
6樓2013-07-17 21:58:30
cpuyou
鐵桿木蟲 (職業(yè)作家)
圣行者
- 應(yīng)助: 82 (初中生)
- 金幣: 9903.5
- 紅花: 19
- 帖子: 3698
- 在線: 815.7小時(shí)
- 蟲號(hào): 840835
- 注冊(cè): 2009-09-05
- 性別: GG
- 專業(yè): 藥劑學(xué)
★
小木蟲: 金幣+0.5, 給個(gè)紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個(gè)紅包，謝謝回帖
| 姑且大膽推測(cè)一下，本朝的反貪反腐，基本都是權(quán)力斗爭(zhēng)的犧牲品，最大可能是上頭利益分配不均造成的。至于后續(xù)，不論是GSK還是各級(jí)機(jī)關(guān)，都會(huì)努力將矛盾歸于GSK公司內(nèi)部。這是整個(gè)行業(yè)的潛規(guī)則，還能把醫(yī)藥行業(yè)整個(gè)翻掉不成？所謂法不責(zé)眾，這是典型的例子。GSK要賠付大筆的堂費(fèi)和賠償國(guó)家大量金錢，而對(duì)本朝百姓，沒(méi)有道歉，而藥價(jià)，也不會(huì)因?yàn)榛疑杀颈唤掖┒兴陆�，相反，為了轉(zhuǎn)移公司用于公關(guān)上層的大筆費(fèi)用，藥價(jià)還有可能猛增。 |
7樓2013-07-18 16:32:40
shenwuyan
鐵蟲 (初入文壇)
- 應(yīng)助: 2 (幼兒園)
- 金幣: 49
- 帖子: 45
- 在線: 10.3小時(shí)
- 蟲號(hào): 1079603
- 注冊(cè): 2010-08-22
- 性別: GG
- 專業(yè): 免疫學(xué)研究新技術(shù)與新方法
8樓2013-07-18 16:56:13
9樓2013-07-18 17:44:16
jason2050
木蟲 (小有名氣)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 2461
- 帖子: 138
- 在線: 161.1小時(shí)
- 蟲號(hào): 1748817
- 注冊(cè): 2012-04-10
- 性別: GG
- 專業(yè): 消化道動(dòng)力異常及功能性胃
10樓2013-07-19 09:11:32
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 冥思苦想 的主題更新
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研]
 271材料工程求調(diào)劑
+7
|
.6lL 2026-03-18 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 265求調(diào)劑 +8 | 梁梁校校 2026-03-19 | 8/400 |
|
|
|
[考研] 一志愿武漢理工材料工程專碩調(diào)劑 +6 | Doleres 2026-03-19 | 6/300 |
|
|
|
[考研] 304求調(diào)劑 +5 | 曼殊2266 2026-03-18 | 5/250 |
|
|
|
[考研] 材料專碩英一數(shù)二306 +6 | z1z2z3879 2026-03-18 | 6/300 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 +10 | 妮妮ninicgb 2026-03-15 | 14/700 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | 18889395102 2026-03-18 | 4/200 |
|
|
|
[考研] 一志愿北京化工大學(xué)0703化學(xué)318分，有科研經(jīng)歷，求調(diào)劑 +3 | 一瓶苯甲酸 2026-03-14 | 3/150 |
|
|
|
[考研] 085600材料與化工調(diào)劑 324分 +10 | llllkkkhh 2026-03-18 | 12/600 |
|
|
|
[考研] 287求調(diào)劑 +3 | 晨昏線與星海 2026-03-19 | 4/200 |
|
|
|
[考研] 331求調(diào)劑（0703有機(jī)化學(xué) +7 | ZY-05 2026-03-13 | 8/400 |
|
|
|
[考研] 304求調(diào)劑 +12 | 小熊joy 2026-03-14 | 13/650 |
|
|
|
[考研] 299求調(diào)劑 +5 | △小透明* 2026-03-17 | 5/250 |
|
|
|
[考研] 278求調(diào)劑 +5 | 煙火先于春 2026-03-17 | 5/250 |
|
|
|
[考研] 藥學(xué)383 求調(diào)劑 +3 | 藥學(xué)chy 2026-03-15 | 4/200 |
|
|
|
[考研] 333求調(diào)劑 +3 | 文思客 2026-03-16 | 7/350 |
|
|
|
[考研] 304求調(diào)劑 +4 | ahbd 2026-03-14 | 4/200 |
|
|
|
[考研] 304求調(diào)劑 +3 | 曼殊2266 2026-03-14 | 3/150 |
|
|
|
[考研] 中科院材料273求調(diào)劑 +4 | yzydy 2026-03-15 | 4/200 |
|
|
|
[考研] 本科南京大學(xué)一志愿川大藥學(xué)327 +3 | 麥田耕者 2026-03-14 | 3/150 |
|